Treatment options and formulary considerations in the management of acid suppression in critically ill patients. Introduction.
Devlin
John W
JW
Northeastern University School of Pharmacy, and Medical Intensive Care Unit, Tufts-New England Medical Center, Mugar #206, 360 Huntington Avenue, Boston, MA 02115, USA. j.devlin@neu.edu
D016638:Critical Illness; D005569:Formularies as Topic; D005744:Gastric Acid / Q000378:metabolism*; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D013315:Stress, Psychological / Q000150:complications / Q000503:physiopathology; D014481:United States
D005765:Gastrointestinal Agents